Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neurosurgery
  Free Subscription

Articles published in
Int J Radiat Oncol Biol Phys
    April 2024
  1. BAKER S, Lechner L, Liu M, Chang JS, et al
    Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:1497-1506.
    >> Share

  2. LYNCH C, Korpics MC, Katipally RR, Wu T, et al
    Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials.
    Int J Radiat Oncol Biol Phys. 2024;118:1519-1530.
    >> Share

  3. MERCIER C, Billiet C, Ost P, Joye I, et al
    Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1490-1496.
    >> Share

    March 2024
  4. FAROOQI AS, Yoder AK, Lin HY, Pasalic D, et al
    SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;118:971-978.
    >> Share

  5. NEILSEN BK, Ma TM, Akingbemi WO, Neylon J, et al
    Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Rad
    Int J Radiat Oncol Biol Phys. 2024;118:986-997.
    >> Share

  6. MILANO MT, Doucette C, Mavroidis P, Yorke E, et al
    Hypofractionated Stereotactic Radiation Therapy Dosimetric Tolerances for the Inferior Aspect of the Brachial Plexus: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2024;118:931-943.
    >> Share

    February 2024
  7. REDMOND KJ, Hattangadi-Gluth J, Pollum EL, Trifiletti DM, et al
    Navigating the Spinal Frontier: Recent Data on Stereotactic Body Radiation Therapy for Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2024;118:313-317.
    >> Share

  8. MITTAUER KE, Tolakanahalli R, Kotecha R, Chuong MD, et al
    Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation.
    Int J Radiat Oncol Biol Phys. 2024;118:512-524.
    >> Share

  9. REMMERTS DE VRIES IF, Verbakel WFAR, Adema M, Slotman BJ, et al
    Spine Stereotactic Body Radiation Therapy Without Immobilization: Detailed Analysis of Intrafraction Motion Using High-Frequency kV Imaging During Irradiation.
    Int J Radiat Oncol Biol Phys. 2024;118:525-532.
    >> Share

  10. BAE SH, Chun SJ, Chung JH, Kim E, et al
    Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.
    Int J Radiat Oncol Biol Phys. 2024;118:337-351.
    >> Share

    January 2024
  11. TRAN PT, Mouw KW
    SABR Today . . . and Tomorrow?
    Int J Radiat Oncol Biol Phys. 2024;118:11.
    >> Share

  12. VELLAYAPPAN B, Lim-Fat MJ, Kotecha R, De Salles A, et al
    A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
    Int J Radiat Oncol Biol Phys. 2024;118:14-28.
    >> Share

    December 2023
  13. NEYLON J, Ma TM, Savjani R, Low DA, et al
    Quantifying Intrafraction Motion and the Impact of Gating for MRI-guided Stereotactic Radiotherapy for Prostate Cancer: Analysis of the MRI arm from the MIRAGE Phase III Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 29:S0360-3016(23)08309.
    >> Share

  14. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
    Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
    >> Share

  15. BASSETTI MF, Morris BA, Sethakorn N, Lang JM, et al
    Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase Ib Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08166.
    >> Share

  16. SAFAVI AH, Palma DA, Giuliani ME
    Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?
    Int J Radiat Oncol Biol Phys. 2023;117:1232-1235.
    >> Share

  17. SIVA S, Staehler M
    The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
    Int J Radiat Oncol Biol Phys. 2023;117:1047.
    >> Share

  18. GHALIBAFIAN M, Mirzaei S, Girinsky T, Sadeghi Y, et al
    Challenges in Treating Childhood Infratentorial Ependymoma: A Low- and Middle-Income Country Experience.
    Int J Radiat Oncol Biol Phys. 2023;117:1181-1190.
    >> Share

  19. LINDBERG S, Grozman V, Karlsson K, Onjukka E, et al
    Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2023;117:1222-1231.
    >> Share

  20. LAWRENCE TS, Aryal MP, Evans JR, Cuneo KC, et al
    Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?
    Int J Radiat Oncol Biol Phys. 2023;117:1236-1240.
    >> Share

    November 2023
  21. RITTER AR, Miller ED
    No Regrets About SABR for NETs.
    Int J Radiat Oncol Biol Phys. 2023;117:786.
    >> Share

  22. PARIKH PJ, Lee P, Low DA, Kim J, et al
    A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:799-808.
    >> Share

    September 2023
  23. JEON SH, Jang BS, Kim DY, Kim JH, et al
    Dynamic responses of circulating T cells following stereotactic body radiotherapy for bone metastasis in patients with breast cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 22:S0360-3016(23)07932.
    >> Share

  24. LIU F, Ververs JD, Farris MK, William Blackstock A Jr, et al
    Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 19:S0360-3016(23)07929.
    >> Share

  25. PRABHU RS, Akinyelu T, Vaslow ZK, Matsui JK, et al
    Single Fraction vs. Fractionated Preoperative Radiosurgery for Resected Brain Metastases: a PROPS-BM International Multicenter Cohort Study.
    Int J Radiat Oncol Biol Phys. 2023 Sep 15:S0360-3016(23)07924.
    >> Share

  26. ZABROCKA E, Polce S, Roberson JD, Wu J, et al
    Utility of Stereotactic Body Radiation Therapy (SBRT) in Establishing Local Control for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery.
    Int J Radiat Oncol Biol Phys. 2023 Sep 12:S0360-3016(23)07908.
    >> Share

  27. OWEN D, Siva S, Salama JK, Daly M, et al
    Some Like It Hot: The Value of Dose and Hot Spots in Lung Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;117:1-5.
    >> Share

  28. MENDEZ ROMERO A, van der Holt B, Willemssen FEJA, de Man RA, et al
    Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial).
    Int J Radiat Oncol Biol Phys. 2023;117:45-52.
    >> Share

  29. REYNGOLD M, Karam SD, Hajj C, Wu AJ, et al
    Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:53-63.
    >> Share

    August 2023
  30. GUAN J, Sun K, Guerrero CA, Zheng J, et al
    A Phase 2 study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Aug 23:S0360-3016(23)07836.
    >> Share

  31. UPADHYAY R, Ayan AS, Jain S, Klamer BG, et al
    Dose/volume tolerance of the brain and predictors of radiation necrosis after three-fraction radiosurgery for brain metastases: A large single-institutional analysis.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07730.
    >> Share

  32. SHINYA Y, Hasegawa H, Shin M, Kashiwabara K, et al
    Age-Dependent Hemorrhage Risk and Obliteration Benefit After Radiosurgery for Brain Arteriovenous Malformation.
    Int J Radiat Oncol Biol Phys. 2023;116:1126-1134.
    >> Share

    July 2023
  33. KIM IA, Winter KA, Sperduto PW, Santos JFL, et al
    Concurrent lapatinib with brain radiotherapy in HER2+ breast cancer patients with brain metastases - NRG ONCOLOGY-KROG/ RTOG 1119 phase II randomized trial.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07681.
    >> Share

  34. OLIVER DE, Laborde JM, Singh DP, Milano MT, et al
    Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2023;116:849-857.
    >> Share

  35. AMINI A, Rusthoven CG
    Ablative Radiation Therapy for Oligometastatic EGFR-Mutated Non-small Cell Lung Cancer: Who, Why, When, and How?
    Int J Radiat Oncol Biol Phys. 2023;116:481.
    >> Share

    June 2023
  36. CRUZ-LIM EM, Cereno RE, Canal JP, Vega G Jr, et al
    Challenges to Improving Access to Stereotactic Body Radiation Therapy and Radiosurgery in the Philippines: A Case Study for Lower-Middle Income Countries.
    Int J Radiat Oncol Biol Phys. 2023;116:430-438.
    >> Share

    May 2023
  37. MORRIS BA, Holmes EE, Anger NJ, Cooley G, et al
    Toxicity and Patient Reported QoL Outcomes Following Prostate SBRT with Focal Boost to MRI Identified Prostate Cancer Lesions: Results of a Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2023 May 11:S0360-3016(23)00446.
    >> Share

    April 2023
  38. ECHEVARRIA MI, Yang GQ, Chen DT, Kirtane K, et al
    Phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent squamous cell carcinoma of the head and neck.
    Int J Radiat Oncol Biol Phys. 2023 Apr 25:S0360-3016(23)00366.
    >> Share

  39. BUCKNELL NW, Kron T, Herschtal A, Hardcastle N, et al
    Comparison of changes in pulmonary function following stereotactic body radiotherapy versus conventional 3D conformal radiotherapy for stage I and IIa non-small cell lung cancer: an analysis of the TROG 09.02 (CHISEL) phase III trial.
    Int J Radiat Oncol Biol Phys. 2023 Apr 20:S0360-3016(23)00369.
    >> Share

  40. WU TC, Stube A, Felix C, Oseguera D, et al
    Safety and Efficacy Results from iSABR, a Phase I Study of Stereotactic Ablative Radiotherapy (SABR) in Combination with Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2023 Apr 4:S0360-3016(23)00325.
    >> Share

  41. GREER MD, Koger B, Glenn M, Kang J, et al
    Predicted Inferior Outcomes for Lung SBRT With Treatment Planning Systems That Fail Independent Phantom-Based Audits.
    Int J Radiat Oncol Biol Phys. 2023;115:1301-1308.
    >> Share

    March 2023
  42. NGUYEN EK, Poon I, Ung YC, Tsao M, et al
    Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:897-905.
    >> Share

  43. SONG X, Wei J, Sun R, Jiang W, et al
    Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Pain Relief for Bone Metastases: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023;115:909-921.
    >> Share

  44. ZENG KL, Abugarib A, Soliman H, Myrehaug S, et al
    Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
    Int J Radiat Oncol Biol Phys. 2023;115:686-695.
    >> Share

  45. WEI L, Simeth J, Aryal MP, Matuszak M, et al
    The Effect of Stereotactic Body Radiation Therapy for Hepatocellular Cancer on Regional Hepatic Liver Function.
    Int J Radiat Oncol Biol Phys. 2023;115:794-802.
    >> Share

    February 2023
  46. LIVERINGHOUSE CL, Mills MN, Ahmed KA, Washington IR, et al
    Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Feb 14:S0360-3016(22)03689.
    >> Share

  47. HATHOUT L, Fields EC, Erickson BA
    Stereotactic Body Radiation Therapy for Nodal Metastases in Gynecologic Cancers: Is it the Swan Song or the Opening Number?
    Int J Radiat Oncol Biol Phys. 2023;115:297-301.
    >> Share

    January 2023
  48. LEHRER EJ, Kowalchuk RO, Gurewitz J, Bernstein K, et al
    Concurrent administration of immune checkpoint inhibitors and single fraction stereotactic radiosurgery in patients with non-small cell lung cancer, melanoma, and renal cell carcinoma brain metastases is not associated with an increased risk of radiat
    Int J Radiat Oncol Biol Phys. 2023 Jan 20:S0360-3016(23)00057.
    >> Share

  49. TRIFILETTI DM, Redmond KJ, Kim MM, Soltys SG, et al
    Novel Applications of Stereotactic Radiosurgery Beyond Oncology: Prospective Trials in Functional Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2023;115:4-6.
    >> Share

    December 2022
  50. LOURENCO RA, Khoo T, Crothers A, Haas M, et al
    Cost-Effectiveness of Single Versus Multifraction SABR for Pulmonary Oligometastases: The SAFRON II Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:968-976.
    >> Share

  51. TSAI CJ
    Moving Away From Counting the Numbers: Leveraging a Sensible Clinical Trial Design for Oligometastatic Disease and Beyond.
    Int J Radiat Oncol Biol Phys. 2022;114:846-848.
    >> Share

  52. KATIPALLY RR, Olson AC, Chmura SJ
    Flipping the Null: Lessons From Breast Cancer and Recalibrating Expectations in Oligometastases.
    Int J Radiat Oncol Biol Phys. 2022;114:840-842.
    >> Share

  53. PALMA DA
    Oligometastases: Learning From the Past, Building for the Future.
    Int J Radiat Oncol Biol Phys. 2022;114:833-835.
    >> Share

  54. BAKER S, Mou B, Jiang W, Liu M, et al
    Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:849-855.
    >> Share

  55. BARRY AS, Bezjak A, Helou J, Goodwin P, et al
    The Impact of Disease Progression on Health-Related Quality of Life Outcomes in Patients With Oligometastatic Disease at 12 Months Post Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;114:989-999.
    >> Share

  56. WONG RKS, Liu ZA, Barry A, Rogalla P, et al
    Patient-Reported and Clinical Outcomes From 5-Fraction SBRT for Oligometastases: A Prospective Single-Institution Study.
    Int J Radiat Oncol Biol Phys. 2022;114:1000-1010.
    >> Share

  57. CHETTY IJ, Doemer AJ, Dolan JL, Kim JP, et al
    MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges.
    Int J Radiat Oncol Biol Phys. 2022;114:950-967.
    >> Share

  58. BAKER S, Mou B, Jiang W, Liu M, et al
    Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:856-861.
    >> Share

  59. SCHIFF JP, Stowe HB, Price A, Laugeman E, et al
    In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases.
    Int J Radiat Oncol Biol Phys. 2022;114:1022-1031.
    >> Share

  60. CHEN H, Badellino S, Biswas T, Dagan R, et al
    Conditional Survival of Patients With Extracranial Oligometastatic Treated With Stereotactic Body Radiation Therapy: An International Consortium Study.
    Int J Radiat Oncol Biol Phys. 2022;114:902-909.
    >> Share

  61. SIVA S, Jones G, Bressel M, Shaw M, et al
    Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases.
    Int J Radiat Oncol Biol Phys. 2022;114:862-870.
    >> Share

  62. WILLMANN J, Vlaskou Badra E, Adilovic S, Christ SM, et al
    Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic Disease.
    Int J Radiat Oncol Biol Phys. 2022;114:871-882.
    >> Share

  63. VERMA V, Yegya-Raman N, Sprave T, Han G, et al
    A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases.
    Int J Radiat Oncol Biol Phys. 2022;114:977-988.
    >> Share

  64. ASHRAM S, Bahig H, Barry A, Blanchette D, et al
    Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:1011-1015.
    >> Share

  65. YANG DD, Brennan VS, Huynh E, Williams CL, et al
    Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Abdominopelvic Oligometastases.
    Int J Radiat Oncol Biol Phys. 2022;114:941-949.
    >> Share

  66. VAN OIRSCHOT M, Bergman A, Verbakel WFAR, Ward L, et al
    Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:1016-1021.
    >> Share

  67. CHEN H, Poon I, Atenafu EG, Badellino S, et al
    Development of a Prognostic Model for Overall Survival in Patients With Extracranial Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;114:892-901.
    >> Share

    November 2022
  68. TRAN PT, Sutera P, Phillips RM, Deek MP, et al
    From Idea to Clinical Practice: A Brief History of Oligometastatic Disease.
    Int J Radiat Oncol Biol Phys. 2022;114:576-580.
    >> Share

  69. GLICKSMAN RM, Palma DA, Deek MP, Tsai CJ, et al
    Stereotactic Body Radiation Therapy for Oligometastasis: GUst Do It?
    Int J Radiat Oncol Biol Phys. 2022;114:561-570.
    >> Share

  70. JABBOUR SK, Yom SS
    The Oligometastatic State: Balancing Between Cure and Palliation.
    Int J Radiat Oncol Biol Phys. 2022;114:559-560.
    >> Share

  71. NAVARRIA P, Baldaccini D, Clerici E, Marini B, et al
    Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study.
    Int J Radiat Oncol Biol Phys. 2022;114:762-770.
    >> Share

  72. KIM H, Venkatesulu BP, McMillan MT, Verma V, et al
    Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2022;114:676-683.
    >> Share

  73. ELAMIR AM, Karalis JD, Sanford NN, Polanco PM, et al
    Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes.
    Int J Radiat Oncol Biol Phys. 2022;114:792-802.
    >> Share

  74. MADANI I, Sahgal A, Erler D, Stish BJ, et al
    Stereotactic Body Radiation Therapy for Metastases in Long Bones.
    Int J Radiat Oncol Biol Phys. 2022;114:738-746.
    >> Share

  75. THOMAS MC, Chen YH, Fite E, Pangilinan A, et al
    Patient and Treatment Factors Associated With Improved Local Control and Survival in Oligometastatic Bone Disease: Results From a Large Single-Institution Experience Using Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;114:747-761.
    >> Share

  76. KORPICS MC, Katipally RR, Partouche J, Cutright D, et al
    Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy.
    Int J Radiat Oncol Biol Phys. 2022;114:645-654.
    >> Share

  77. NEVENS D, Jongen A, Kindts I, Billiet C, et al
    Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC Nomenclature.
    Int J Radiat Oncol Biol Phys. 2022;114:587-595.
    >> Share

  78. BAKER S, Jiang W, Mou B, Lund CR, et al
    Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:617-626.
    >> Share

  79. GUTKIN PM, von Eyben R, Chin A, Donaldson SS, et al
    Local Control Outcomes Using Stereotactic Body Radiation Therapy or Surgical Resection for Metastatic Sarcoma.
    Int J Radiat Oncol Biol Phys. 2022;114:771-779.
    >> Share

  80. HARROW S, Palma DA, Olson R, Gaede S, et al
    Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes.
    Int J Radiat Oncol Biol Phys. 2022;114:611-616.
    >> Share

  81. MILANO MT, Soltys SG, Marks LB, Heron DE, et al
    The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2022 Nov 15:S0360-3016(22)00757.
    >> Share

    October 2022
  82. ARCIDIACONO F, Anselmo P, Casale M, Zannori C, et al
    STereotactic Ablative RadioTherapy in NEWly diagnosed and recurrent locally advanced non-small cell lung cancer patients unfit for concurrEnt RAdio-chemotherapy: early analysis of the START-NEW-ERA non-randomised phase II trial.
    Int J Radiat Oncol Biol Phys. 2022 Oct 23. pii: S0360-3016(22)03459.
    >> Share

  83. FAIRCHILD AT, Salama JK, Wiggins WF, Ackerson BG, et al
    A Deep Learning-Based Computer Aided Detection (CAD) System for Difficult-to-Detect Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2022 Oct 21. pii: S0360-3016(22)03392.
    >> Share

  84. KLUGE A, Ehrbar S, Grehn M, Fleckenstein J, et al
    Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:360-372.
    >> Share

  85. ZENG KL, Myrehaug S, Soliman H, Husain ZA, et al
    Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;114:293-300.
    >> Share

  86. BUCKSTEIN M, Kim E, Ozbek U, Tabrizian P, et al
    Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2022;114:221-230.
    >> Share

    September 2022
  87. PINZI V, Marchetti M, Viola A, Tramacere I, et al
    HYPOFRACTIONATED RADIOSURGERY FOR LARGE OR IN CRITICAL SITE INTRACRANIAL MENINGIOMA: RESULTS OF A PHASE II PROSPECTIVE STUDY.
    Int J Radiat Oncol Biol Phys. 2022 Sep 5. pii: S0360-3016(22)03236.
    >> Share

  88. OWEN D, Siva S, Salama JK, Robinson C, et al
    If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:5-9.
    >> Share

    August 2022
  89. MA TM, Ballas LK, Wilhalme H, Sachdeva A, et al
    Quality-of-Life Outcomes and Toxicity Profile Among Patients with Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multi-Center Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2022 Aug 22. pii: S0360-3016(22)03160.
    >> Share

  90. KHATTAB MH, Sherry AD, Devan SP, Luo G, et al
    Noninvasive Capsulotomy for Refractory Depression by Frameless Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2022;113:960-966.
    >> Share

    July 2022
  91. CHINNIAH S, Stish B, Costello BA, Pagliaro L, et al
    Radiotherapy in Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 22. pii: S0360-3016(22)00732.
    >> Share

  92. HAMMER L, Jiang R, Hearn J, Lashbrook J, et al
    A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 22. pii: S0360-3016(22)00736.
    >> Share

  93. SHARMA M, Milano MT, Cummings M, Naqa IE, et al
    Tumor Control Probability following Radiosurgery of Brain Metastases with and without Retreatment.
    Int J Radiat Oncol Biol Phys. 2022 Jul 18. pii: S0360-3016(22)00721.
    >> Share

  94. HATHOUT L, Harkenrider MM
    Rays Over Knife.
    Int J Radiat Oncol Biol Phys. 2022;113:716-717.
    >> Share

  95. MOON DH, Sher DJ
    Oligometastasis in head and neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Jul 4. pii: S0360-3016(22)00660.
    >> Share

  96. HAMMER L, Hausner D, Ben-Ayun M, Shacham-Shmueli E, et al
    Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2022;113:588-593.
    >> Share

  97. SHINYA Y, Hasegawa H, Shin M, Kawashima M, et al
    High Dose Radiosurgery Targeting the Primary Tumor Sites Contributes to Survival in Patients With Skull Base Chordoma.
    Int J Radiat Oncol Biol Phys. 2022;113:582-587.
    >> Share

    June 2022
  98. MURTHY V, Adsul K, Maitre P, Singhla A, et al
    Acute and late toxicity of prostate-only or pelvic SBRT in prostate cancer: A Comparative Study.
    Int J Radiat Oncol Biol Phys. 2022 Jun 17. pii: S0360-3016(22)00607.
    >> Share

  99. LUCIEN F, Kim Y, Qian J, Orme JJ, et al
    Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity.
    Int J Radiat Oncol Biol Phys. 2022 Jun 4. pii: S0360-3016(22)00544.
    >> Share

  100. VICENTE EM, Modiri A, Kipritidis J, Yu KC, et al
    Combining Serial and Parallel Functionality in Functional Lung Avoidance Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:456-468.
    >> Share

    May 2022
  101. NO HJ, Raja N, Von Eyben R, Das M, et al
    Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms.
    Int J Radiat Oncol Biol Phys. 2022 May 30. pii: S0360-3016(22)00476.
    >> Share

  102. MOUSTAKIS C, Blanck O, Chan MKH, Boda-Heggemann J, et al
    Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2022;113:214-227.
    >> Share

    April 2022
  103. ADAM JF, Balosso J, Bayat S, Berkvens P, et al
    Towards neuro-oncologic clinical trials of high dose rate synchrotron Microbeam Radiation Therapy: first treatment of a spontaneous canine brain tumor.: First microbeam treatment of canine brain tumor.
    Int J Radiat Oncol Biol Phys. 2022 Apr 25. pii: S0360-3016(22)00335.
    >> Share

  104. PIELKENROOD BJ, Gal R, Kasperts N, Verhoeff JJC, et al
    Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2022;112:1203-1215.
    >> Share

  105. SODJI QH, Ko R, von Eyben R, Owen SG, et al
    Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus.
    Int J Radiat Oncol Biol Phys. 2022;112:1144-1153.
    >> Share

    March 2022
  106. JIAO Z, Li H, Xiao Y, Dorsey J, et al
    Integration of Deep Learning Radiomics and Counts of Circulating Tumor Cells Improves Prediction of Outcomes of Early Stage NSCLC Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:1045-1054.
    >> Share

  107. SWAMINATH A, Ritter T, Louie AV, Palma DA, et al
    Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus?
    Int J Radiat Oncol Biol Phys. 2022;112:586-589.
    >> Share

  108. MENDIRATTA-LALA M, Aslam A, Maturen KE, Westerhoff M, et al
    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;112:704-714.
    >> Share

    February 2022
  109. HRYCUSHKO B, van der Kogel AJ, Phillips L, Chhabra A, et al
    Brachial Plexus Tolerance to Single-Session SABR in a Pig Model.
    Int J Radiat Oncol Biol Phys. 2022;112:565-571.
    >> Share

  110. NGUYEN TK, Chin L, Sahgal A, Dagan R, et al
    International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2022;112:351-360.
    >> Share

    January 2022
  111. MATHIS NJ, Doyle CJ, Rosen DB, Wijetunga NA, et al
    Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2022;112:99-105.
    >> Share

  112. LEEMAN JE, Chen YH, Catalano P, Bredfeldt J, et al
    Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2022;112:75-82.
    >> Share

  113. KHATTAB MH, Cmelak AJ, Sherry AD, Luo G, et al
    Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2022;112:121-130.
    >> Share

  114. DUNNE EM, Lo SS, Liu MC, Bergman A, et al
    Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe Practice.
    Int J Radiat Oncol Biol Phys. 2022;112:114-120.
    >> Share

  115. MILLER JA, Toesca DAS, Baclay JRM, Vitzthum LK, et al
    Pancreatic Stereotactic Body Radiation Therapy With or Without Hypofractionated Elective Nodal Irradiation.
    Int J Radiat Oncol Biol Phys. 2022;112:131-142.
    >> Share

    December 2021
  116. LEE K, Le T, Hau E, Hanna GG, et al
    A systematic review into the radiological features predicting local recurrence after stereotactic ablative body radiotherapy (SABR) in patients with non-small cell lung cancer (NSCLC): Local recurrence features of NSCLC post-SABR.
    Int J Radiat Oncol Biol Phys. 2021 Dec 5. pii: S0360-3016(21)03235.
    >> Share

  117. NIEDZIELSKI JS, Liu Y, Ng SSW, Martin RM, et al
    Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image Guidance.
    Int J Radiat Oncol Biol Phys. 2021;111:1298-1309.
    >> Share

    November 2021
  118. UEKI K, Matsuo Y, Takeda A, Morita S, et al
    Impact of local recurrence on cause-specific death after stereotactic body radiotherapy for early-stage non-small cell lung cancer: dynamic prediction using landmark model.
    Int J Radiat Oncol Biol Phys. 2021 Nov 25. pii: S0360-3016(21)03223.
    >> Share

  119. CHEN X, Redmond KJ
    There Will Be Blood: Not All AVM Complications Are Due to Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111:855.
    >> Share

  120. ITO K, Sugita S, Nakajima Y, Furuya T, et al
    Phase II Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  121. YANG HC, Wu HM, Peng SJ, Lee CC, et al
    The Irradiated Brain Volume Within 12 Gy Is a Predictor for Radiation-Induced Changes After Stereotactic Radiosurgery in Patients With Unruptured Cerebral Arteriovenous Malformations.
    Int J Radiat Oncol Biol Phys. 2021;111:785-793.
    >> Share

    October 2021
  122. KOWALCHUK RO, Niranjan A, Lee CC, Yang HC, et al
    yReirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery.
    Int J Radiat Oncol Biol Phys. 2021 Oct 10. pii: S0360-3016(21)02904.
    >> Share

  123. RABEN D, Raben A
    A Two-Headed Heated Debate.
    Int J Radiat Oncol Biol Phys. 2021;111:310.
    >> Share

  124. PERDOMO-PANTOJA A, Holmes C, Lina IA, Liauw JA, et al
    Effects of Single-Dose Versus Hypofractionated Focused Radiation on Vertebral Body Structure and Biomechanical Integrity: Development of a Rabbit Radiation-Induced Vertebral Compression Fracture Model.
    Int J Radiat Oncol Biol Phys. 2021;111:528-538.
    >> Share

    September 2021
  125. AMINI A, Verma V, Simone CB 2nd, Chetty IJ, et al
    American Radium Society Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Sep 24. pii: S0360-3016(21)02823.
    >> Share

  126. MYREHAUG S, Hudson J, Soliman H, Ruschin M, et al
    Hypofractionated Stereotactic Radiotherapy for Intact Brain Metastases in 5 Daily Fractions: Impact of Dose on Treatment Response.
    Int J Radiat Oncol Biol Phys. 2021 Sep 16. pii: S0360-3016(21)02784.
    >> Share

  127. NAGAR H, Spratt DE
    Prostate SBRT Dose Escalation (9 Gyx5, 13.3 Gyx3, 24 Gyx1): Are We Making Progress?
    Int J Radiat Oncol Biol Phys. 2021;111:110-112.
    >> Share

  128. REDMOND KJ, De Salles AAF, Fariselli L, Levivier M, et al
    Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
    Int J Radiat Oncol Biol Phys. 2021;111:68-80.
    >> Share

  129. JACKSON WC, Hartman HE, Gharzai LA, Maurino C, et al
    The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:127-134.
    >> Share

  130. BROWNSTEIN J, Afzal M, Okabe T, Harfi TT, et al
    Method and Atlas to Enable Targeting for Cardiac Radioablation Employing the American Heart Association Segmented Model.
    Int J Radiat Oncol Biol Phys. 2021;111:178-185.
    >> Share

  131. MAGALLON-BARO A, Milder MTW, Granton PV, Nuyttens JJ, et al
    Comparison of Daily Online Plan Adaptation Strategies for a Cohort of Pancreatic Cancer Patients Treated with SBRT.
    Int J Radiat Oncol Biol Phys. 2021;111:208-219.
    >> Share

    August 2021
  132. HENKE LE, Stanley JA, Robinson C, Srivastava A, et al
    Phase I Trial of Stereotactic MRI-guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Aug 30. pii: S0360-3016(21)02726.
    >> Share

  133. ITO K, Ogawa H
    Stereotactic Body Radiation Therapy for Patients With Sacral Chordoma Who Previously Received Carbon Ion Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:1263-1264.
    >> Share

  134. MOORE C, Hsu CC, Chen WM, Chen BPC, et al
    Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade.
    Int J Radiat Oncol Biol Phys. 2021;110:1306-1316.
    >> Share

  135. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    >> Share

    July 2021
  136. ITO K, Sugita S, Nakajima Y, Furuya T, et al
    Phase II clinical trial of separation surgery followed by stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Int J Radiat Oncol Biol Phys. 2021 Jul 23. pii: S0360-3016(21)02560.
    >> Share

  137. SOYFER V, Gutfeld O, Shamai S, Schlocker A, et al
    COVID-19 Vaccine-Induced Radiation Recall Phenomenon.
    Int J Radiat Oncol Biol Phys. 2021;110:957-961.
    >> Share

  138. CHOUDHURY A, Henry Md Frcr A, Mitin Md PhD T, Chen Md Mph R, et al
    Photons, Protons, SBRT, Brachytherapy-What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team.
    Int J Radiat Oncol Biol Phys. 2021;110:1114-1121.
    >> Share

  139. COURTNEY PT, Paravati AJ, Atwood TF, Raja N, et al
    Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:1003-1012.
    >> Share

  140. MARGULIS V, Freifeld Y, Pop LM, Manna S, et al
    Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:1135-1142.
    >> Share

  141. BISWAS T, Spratt DE
    Dose Escalation for Oligometastatic Disease: Is More Better?
    Int J Radiat Oncol Biol Phys. 2021;110:680-681.
    >> Share

  142. BODA-HEGGEMANN J, Blanck O, Mehrhof F, Ernst F, et al
    Interdisciplinary Clinical Target Volume Generation for Cardiac Radioablation: Multicenter Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:745-756.
    >> Share

  143. VAN DAMS R, Jiang NY, Fuller DB, Loblaw A, et al
    Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
    Int J Radiat Oncol Biol Phys. 2021;110:731-737.
    >> Share

  144. ZELEFSKY MJ, Yamada Y, Greco C, Lis E, et al
    Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:672-679.
    >> Share

    June 2021
  145. HOSKIN MD FRCR P
    Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2, Randomized Controlled Trial Within a Prospective Cohort.
    Int J Radiat Oncol Biol Phys. 2021;110:368-370.
    >> Share

  146. GUCKENBERGER M, Mantel F, Sweeney RA, Hawkins M, et al
    Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Int J Radiat Oncol Biol Phys. 2021;110:348-357.
    >> Share

  147. PARK JH, Kim HY, Lee A, Seo YK, et al
    Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1.
    Int J Radiat Oncol Biol Phys. 2021;110:510-520.
    >> Share

  148. PIELKENROOD BJ, van der Velden JM, van der Linden YM, Bartels MMT, et al
    Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
    Int J Radiat Oncol Biol Phys. 2021;110:358-367.
    >> Share

    May 2021
  149. PRABHU RS, Dhakal R, Vaslow ZK, Dan T, et al
    Preoperative radiosurgery for resected brain metastases: the PROPS-BM multicenter cohort study.
    Int J Radiat Oncol Biol Phys. 2021 May 28. pii: S0360-3016(21)00666.
    >> Share

  150. VIDETIC GMM, Reddy CA, Woody NM, Stephans KL, et al
    Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00658.
    >> Share

  151. STUMPF PK, Yorke ED, El Naqa I, Cuneo KC, et al
    Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors.
    Int J Radiat Oncol Biol Phys. 2021;110:217-226.
    >> Share

  152. GRIMM J, Marks LB, Jackson A, Kavanagh BD, et al
    High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview.
    Int J Radiat Oncol Biol Phys. 2021;110:1-10.
    >> Share

  153. GRIMM J, Vargo JA, Mavroidis P, Moiseenko V, et al
    Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Int J Radiat Oncol Biol Phys. 2021;110:147-159.
    >> Share

  154. SOLTYS SG, Grimm J, Milano MT, Xue J, et al
    Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Int J Radiat Oncol Biol Phys. 2021;110:112-123.
    >> Share

  155. MAHADEVAN A, Moningi S, Grimm J, Li XA, et al
    Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:206-216.
    >> Share

  156. WANG K, Mavroidis P, Royce TJ, Falchook AD, et al
    Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.
    Int J Radiat Oncol Biol Phys. 2021;110:237-248.
    >> Share

  157. MILANO MT, Grimm J, Niemierko A, Soltys SG, et al
    Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Int J Radiat Oncol Biol Phys. 2021;110:68-86.
    >> Share

  158. SAHGAL A, Chang JH, Ma L, Marks LB, et al
    Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:124-136.
    >> Share

  159. LEE P, Loo BW Jr, Biswas T, Ding GX, et al
    Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:160-171.
    >> Share

  160. MARCISCANO AE, Haimovitz-Friedman A, Lee P, Tran PT, et al
    Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:35-52.
    >> Share

  161. SONG CW, Glatstein E, Marks LB, Emami B, et al
    Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
    Int J Radiat Oncol Biol Phys. 2021;110:21-34.
    >> Share

  162. KONG FS, Moiseenko V, Zhao J, Milano MT, et al
    Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
    Int J Radiat Oncol Biol Phys. 2021;110:172-187.
    >> Share

  163. MILANO MT, Grimm J, Soltys SG, Yorke E, et al
    Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
    Int J Radiat Oncol Biol Phys. 2021;110:87-99.
    >> Share

  164. MIFTEN M, Vinogradskiy Y, Moiseenko V, Grimm J, et al
    Radiation Dose-Volume Effects for Liver SBRT.
    Int J Radiat Oncol Biol Phys. 2021;110:196-205.
    >> Share

  165. OHRI N, Tome WA, Mendez Romero A, Miften M, et al
    Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.
    Int J Radiat Oncol Biol Phys. 2021;110:188-195.
    >> Share

    April 2021
  166. TATEISHI Y, Takeda A, Horita N, Tsurugai Y, et al
    Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2021 Apr 20. pii: S0360-3016(21)00375.
    >> Share

  167. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    >> Share

  168. FOLKERT MR, Meyer JJ, Aguilera TA, Yokoo T, et al
    Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1387-1395.
    >> Share

  169. QU XM, Chen Y, Zaric GS, Senan S, et al
    Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1176-1184.
    >> Share

  170. MERCIER C, Claessens M, Buys MSc A, Gryshkevych S, et al
    Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1195-1205.
    >> Share

  171. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    >> Share

  172. TINKLE CL, Singh C, Lloyd S, Guo Y, et al
    Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.
    Int J Radiat Oncol Biol Phys. 2021;109:1396-1405.
    >> Share

  173. ZHANG J, Wang L, Li X, Huang M, et al
    Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking.
    Int J Radiat Oncol Biol Phys. 2021;109:1588-1605.
    >> Share

  174. KUMAR A, Straka C, Courtney PT, Vitzthum L, et al
    Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;109:1185-1194.
    >> Share

    March 2021
  175. MAGLI A, Farneti A, Faiella A, Ferriero M, et al
    Toxicity at 1 year after Stereotactic Body Radiotherapy in 3 Fractions for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 18. pii: S0360-3016(21)00287.
    >> Share

  176. SANTOS PMG, Lapen K, Zhang Z, Lobaugh S, et al
    Trends in Radiation Therapy for Bone Metastases, 2015 to 2017: Choosing Wisely in the Era of Complex Radiation.
    Int J Radiat Oncol Biol Phys. 2021;109:923-931.
    >> Share

  177. ZHANG J, Wang C, Sheng Y, Palta M, et al
    An Interpretable Planning Bot for Pancreas Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1076-1085.
    >> Share

  178. LYDIARD PGDIP S, Blanck O, Hugo G, O'Brien R, et al
    A Review of Cardiac Radioablation (CR) for Arrhythmias: Procedures, Technology, and Future Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;109:783-800.
    >> Share

  179. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    >> Share

  180. SOGONO P, Bressel M, David S, Shaw M, et al
    Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.
    Int J Radiat Oncol Biol Phys. 2021;109:756-763.
    >> Share

    February 2021
  181. KOWALCHUK RO, Shepard MJ, Sheehan K, Sheehan D, et al
    Treatment of WHO grade II meningiomas with stereotactic radiosurgery: identification of an optimal group for SRS using RPA.
    Int J Radiat Oncol Biol Phys. 2021 Feb 3. pii: S0360-3016(21)00122.
    >> Share

  182. DUNNE EM, Liu M
    Postoperative Stereotactic Body Radiation Therapy, Then Observe.
    Int J Radiat Oncol Biol Phys. 2021;109:316.
    >> Share

  183. DE BARI B
    Cautious SBRT.
    Int J Radiat Oncol Biol Phys. 2021;109:315.
    >> Share

  184. KIM N, Cheng J, Huang WY, Kimura T, et al
    Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study.
    Int J Radiat Oncol Biol Phys. 2021;109:464-473.
    >> Share

  185. LO CH, Lee HL, Hsiang CW, Chiou JF, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:474-484.
    >> Share

    January 2021
  186. SALAMA JK, Giuliani ME, Robinson CG, Daly ME, et al
    Single-fraction SBRT for Early Stage NSCLC-A Viable Option in "These Uncertain Times"?
    Int J Radiat Oncol Biol Phys. 2021;109:1-4.
    >> Share

  187. JACKSON WC, Tang M, Maurino C, Mendiratta-Lala M, et al
    Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease.
    Int J Radiat Oncol Biol Phys. 2021;109:212-219.
    >> Share

    December 2020
  188. REDMOND KJ, Gui C, Benedict S, Milano MT, et al
    Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2020 Dec 31. pii: S0360-3016(20)34451.
    >> Share

  189. CHEN WC, Li Y, Lazar A, Altan A, et al
    Stereotactic body radiotherapy and high-dose rate brachytherapy boost in combination with intensity modulated radiotherapy for localized prostate cancer: a single-institution propensity score matched analysis.
    Int J Radiat Oncol Biol Phys. 2020 Dec 29. pii: S0360-3016(20)34730.
    >> Share

  190. SOLTYS SG, Milano MT, Xue J, Tome WA, et al
    Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Int J Radiat Oncol Biol Phys. 2020 Dec 26. pii: S0360-3016(20)34541.
    >> Share

  191. MCDONALD BA, Vedam S, Yang J, Wang J, et al
    Initial Feasibility and Clinical Implementation of Daily MR-guided Adaptive Head and Neck Cancer Radiotherapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34661.
    >> Share

  192. JIAO Z, Li H, Xiao Y, Aggarwal C, et al
    Integration of risk survival measures estimated from pre- and post-treatment CT scans improves stratification of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34660.
    >> Share

  193. TANG C, Lei X, Smith GL, Pan HY, et al
    Influence of Geography on Prostate Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2020 Dec 11. pii: S0360-3016(20)34595.
    >> Share

  194. KIMURA T, Takeda A, Tsurugai Y, Kawano R, et al
    A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1265-1275.
    >> Share

  195. SEBASTIAN NT, Miller ED, Yang X, Diaz DA, et al
    A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1276-1283.
    >> Share

  196. DEE EC, Muralidhar V, Arega MA, Kishan AU, et al
    Factors influencing non-completion of radiotherapy among men with localized prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Dec 1. pii: S0360-3016(20)34604.
    >> Share

    November 2020
  197. SPENCER KL, Tree AC
    Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:927-929.
    >> Share

  198. BURRI SH, Ward MC, Prabhu RS
    Hobgoblins, Iron Lungs, and Surgical Perturbation Failure?
    Int J Radiat Oncol Biol Phys. 2020;108:996-998.
    >> Share

  199. VASQUEZ OSORIO EM, McCallum H, Bedair A, Faivre-Finn C, et al
    Protecting the Heart: A Practical Approach to Account for the Full Extent of Heart Motion in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2020;108:1082-1090.
    >> Share

  200. PARIKH NR, Kundu P, Levin-Epstein R, Chang EM, et al
    Time-Driven Activity-Based Costing Comparison of Stereotactic Radiosurgery to Multiple Brain Lesions Using Single-Isocenter Versus Multiple-Isocenter Technique.
    Int J Radiat Oncol Biol Phys. 2020;108:999-1007.
    >> Share

  201. SIVA S, Correa RJM, Warner A, Staehler M, et al
    Stereotactic Ablative Radiotherapy for >/=T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
    Int J Radiat Oncol Biol Phys. 2020;108:941-949.
    >> Share

  202. GOGINENI E, Rana Z, Soberman D, Sidiqi B, et al
    Biochemical control and toxicity outcomes of SBRT vs LDR brachytherapy in the treatment of low and intermediate risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 7. pii: S0360-3016(20)34489.
    >> Share

  203. JOHNSTONE C, Recht A
    It's Time...
    Int J Radiat Oncol Biol Phys. 2020;108:572-574.
    >> Share

  204. YU JB, Brock KK, Campbell AM, Chen AB, et al
    Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop.
    Int J Radiat Oncol Biol Phys. 2020;108:539-545.
    >> Share

  205. BYUN HK, Yoon HI, Cho J, Shim KW, et al
    Optimization of Intracranial Germinoma Treatment: Radiotherapy Alone with Reduced Volume and Dose.
    Int J Radiat Oncol Biol Phys. 2020;108:657-666.
    >> Share

    October 2020
  206. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    >> Share

    September 2020
  207. SANDERS JW, Venkatesan AM, Levitt CA, Bathala T, et al
    Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study.
    Int J Radiat Oncol Biol Phys. 2020 Sep 24. pii: S0360-3016(20)34342.
    >> Share

  208. ROYCE TJ, Mavroidis P, Wang K, Falchook AD, et al
    Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Sep 5. pii: S0360-3016(20)34102.
    >> Share

  209. KORPICS MC, Polley MY, Bhave SR, Redler G, et al
    A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab.
    Int J Radiat Oncol Biol Phys. 2020;108:189-195.
    >> Share

  210. RATNAYAKE G, Reinwald S, Shackleton M, Moore M, et al
    Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:150-156.
    >> Share

  211. TIAN S, Switchenko JM, Buchwald ZS, Patel PR, et al
    Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
    Int J Radiat Oncol Biol Phys. 2020;108:304-313.
    >> Share

    July 2020
  212. BERGAMIN S, Eade T, Kneebone A, Booth J, et al
    Interim results of a prospective PSMA-directed focal stereotactic re-irradiation trial for locally recurrent prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jul 10. pii: S0360-3016(20)31412.
    >> Share

  213. SANDERS JW, Lewis GD, Thames HD, Kudchadker RJ, et al
    Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jul 4. pii: S0360-3016(20)31396.
    >> Share

  214. TSANG RW, Laperriere N
    Whole Brain Radiation Is Still the Standard in the Salvage Situation.
    Int J Radiat Oncol Biol Phys. 2020;107:403.
    >> Share

  215. BERTHO A, Dos Santos M, Buard V, Paget V, et al
    Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Effect of Beam Size Changes and Dose Effect at Constant Collimation.
    Int J Radiat Oncol Biol Phys. 2020;107:548-562.
    >> Share

    June 2020
  216. HELIS CA, Hughes RT, Glenn CW, Lanier CM, et al
    Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated with Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy.
    Int J Radiat Oncol Biol Phys. 2020 Jun 29. pii: S0360-3016(20)31344.
    >> Share

  217. PARIKH NR, Kishan AU, Kane N, Diaz-Perez S, et al
    Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 17. pii: S0360-3016(20)31251.
    >> Share

  218. PARIKH NR, Chang EM, Nickols NG, Rettig MB, et al
    Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 13. pii: S0360-3016(20)31250.
    >> Share

  219. JACCARD M, Zilli T, Dubouloz A, Escude L, et al
    Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.
    Int J Radiat Oncol Biol Phys. 2020 Jun 11. pii: S0360-3016(20)31242.
    >> Share

  220. CHANG DT, Pollom EL, Keane FK, Wo JY, et al
    Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?
    Int J Radiat Oncol Biol Phys. 2020;107:257-260.
    >> Share

  221. PALMA DA, Bauman GS, Rodrigues GB
    Beyond Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;107:253-256.
    >> Share

  222. FINAZZI T, Haasbeek CJA, Spoelstra FOB, Palacios MA, et al
    Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2020;107:270-278.
    >> Share

  223. AYOUB Z, Ning MS, Brooks ED, Kang J, et al
    Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:261-269.
    >> Share

    May 2020
  224. HASEGAWA T, Kato T, Naito T, Tanei T, et al
    Long-term outcomes of sporadic vestibular schwannomas treated with recent stereotactic radiosurgery techniques.
    Int J Radiat Oncol Biol Phys. 2020 May 28. pii: S0360-3016(20)31186.
    >> Share

  225. CHU C, Davis CM, Lan X, Hienz RD, et al
    Neuroinflammation following stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease.
    Int J Radiat Oncol Biol Phys. 2020 May 26. pii: S0360-3016(20)31151.
    >> Share

  226. RAHIMI A, Zhang Y, Kim DW, Morgan H, et al
    Risk factors for fat necrosis after stereotactic partial breast irradiation (S-PBI) for early stage breast cancer in a phase I clinical trial.
    Int J Radiat Oncol Biol Phys. 2020 May 25. pii: S0360-3016(20)31149.
    >> Share

  227. LIU Q, Zhu Z, Chen Y, Deng J, et al
    Phase II Study of SBRT for Patients With Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 May 14. pii: S0360-3016(20)31127.
    >> Share

  228. KASMANN L, Eze C, Manapov F
    Stereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death?
    Int J Radiat Oncol Biol Phys. 2020 May 12. pii: S0360-3016(20)30987.
    >> Share

  229. VAN DE VEN S, van den Bongard D, Pielkenrood B, Kasperts N, et al
    Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort.
    Int J Radiat Oncol Biol Phys. 2020;107:39-47.
    >> Share

  230. CHEN WC, Baal JD, Baal U, Pai J, et al
    Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients.
    Int J Radiat Oncol Biol Phys. 2020;107:48-61.
    >> Share

  231. ALAYED Y, Davidson M, Liu S, Chu W, et al
    Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2020;107:136-142.
    >> Share

  232. GUO T, Ni J, Yang X, Li Y, et al
    Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:62-71.
    >> Share

    March 2020
  233. KLEMENT RJ, Sonke JJ, Allgauer M, Andratschke N, et al
    Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.
    Int J Radiat Oncol Biol Phys. 2020 Mar 15. pii: S0360-3016(20)30897.
    >> Share

    January 2020
  234. DAUTRUCHE A, Filion E, Mathieu D, Bahig H, et al
    To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation.
    Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30124.
    >> Share

  235. MANYAM BV, Verdecchia K, Videtic GMM, Zhuang T, et al
    Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30068.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016